ICU Volume 15 - Issue 4 - 2015 - Matrix

Acute Brain Dysfunction During Critical Illness

  • Delirium (acute brain dysfunction) can be a complication of critical illness.
  • Brain organ dysfunction can manifest as a continuum of psychomotor behaviors that are categorised as hyperactive or hypoactive.
  • Delirium can be diagnosed using validated and reliable bedside tools.
  • Implementation of delirium monitoring can be enhanced by scheduled in-depth discussions about brain organ dysfunction via multidisciplinary rounds with the medical team.
  • Delirium may be managed with use of non-pharmacologic and, if necessary, pharmacologic interventions thereafter.

Acute brain dysfunction is common in the critical care setting, presenting as delirium or coma. Delirium is a clinical syndrome of brain dysfunction characterised by an acute change or fluctuating course of altered mental status, inattention, and a disturbance of consciousness, cognition, or  perception, such that a patient’s ability to receive, process, store, and recall information is impaired (American Psychiatric Association 2013). 
Prevalence 
The prevalence of delirium among adults varies among different adult ICU populations: 20-30% in the cardiac ICU (McPherson et al. 2013; Pauley et al. 2015; Zhang et al. 2015), and 50%-80% in mechanically ventilated medical, surgical, trauma ICU (Bryczkowski et al. 2014; Pandharipande et al. 2008) and burn ICU (Agarwal et al. 2010) patients. The clinical presentation of delirium is expressed as a continuum of psychomotor behavior. Hypoactive delirium is characterised by apathy and decreased responsiveness (Meagher et al. 2007; Pandharipande et al. 2007). Conversely, patients with hyperactive delirium may exhibit mild restlessness to severe agitation. Among critically ill adults, hypoactive delirium (43.5%) is extremely prevalent versus the less common hyperactive subtype (1.6%) (Pandharipande et al. 2007), and unless routine monitoring is used, delirium will be missed. 
Delirium does occur in critically ill children, although the true epidemiology has yet to be well described. Small case series report paediatric delirium rates of between 10-30% (Smith et al. 2011; Traube et al. 2014; Schieveld et al. 2007). Most recently, Smith and colleagues reported delirium prevalence of 36% in critically ill infants and young children, with rates as high as 46% in patients between 6 months and 2 years of age (Smith et al. 2014). Critically ill children are more likely to present with the hypoactive delirium subtype (81%) than hyperactive delirium (19%) (Goben et al. 2014).
Measurements 
Delirium in the adult ICU can be diagnosed by using the validated Confusion Assessment Method for the ICU (CAM-ICU) (Ely et al. 2001a) or the Intensive Care Delirium Screening Checklist (ICDSC) ( Bergeron et al. 2001). Given the fluctuating course of delirium, it is recommended that patients be screened at least once per shift to increase the chance of detection (Pun et al. 2013). The use of screening tools is superior to subjective assessment by providers and ideally should be part of routine modern ICU practice.
The first step in delirium diagnosis is assessment of level of arousal. Only patients who are responsive to voice can be evaluated for delirium, while those who are unresponsive are considered comatose. The Society of Critical Care Medicine (SCCM) guidelines recommend the use of either the Richmond Agitation-Sedation scale or the Sedation Agitation Scale for the assessment of the level of arousal  (Barr et al. 2013). Patients who are arousable by voice can then be assessed for delirium with the CAM-ICU or the ICDSC, as shown in Figure 1 and Table 1. 
Delirium monitoring in paediatric patients is equally as important, especially during critical illness. Similarly to adult patients with delirium, paediatric patients demonstrate the core features of delirium, such as alteration of mental status, fluctuation and inattention. Additionally, infants and children with delirium may exhibit more subtle neuropsychiatric symptoms, such as inconsolability, purposeless actions, autonomic dysregulation, unexplained lethargy and even regression of previously attained developmental skills ( Leentjens et al. 2008; Turkel et al. 2006).


Recently, there has been progress in the development and validation of paediatric-specific delirium tools. The paediatric confusion assessment method for the ICU (pCAM-ICU) was the first valid and reliable delirium tool created for use in critically ill children over 5 years of age, including those on mechanical ventilation, demonstrating a specificity of 99% and sensitivity of 83% for delirium diagnosis (Smith et al. 2011). 
Children under 5 years of age pose challenges for delirium diagnosis due to vast changes in their cognitive and developmental skills from infancy to early childhood. The Cornell Assessment for Pediatric Delirium (CAPD) is largely an observational delirium screening tool with a reported specificity of 79% and sensitivity of 94% (Traube et al. 2014). Unlike DSM-5 criteria (ed American Psychiatric Association 2013), the CAPD does not require inattention to be present for delirium diagnosis. More recently, the preschool CAM-ICU (psCAM-ICU) was created and validated for use in critically ill infants and preschool-aged children. The psCAM-ICU is a largely objective and interactive, developmentally-targeted, ‘in the moment’ delirium assessment tool for children under 5 years of age. In preliminary validation study reports, the psCAM-ICU demonstrated a specificity of 91% and sensitivity of 84%, with excellent reliability (Smith et al. 2014). 
Risk Factors 
Critically ill adult patients are predisposed to multiple risk factors, and it has been shown that the presence of more risk factors is associated with increased delirium (Francis  et al. 1990; Inouye  et al. 1996). The SCCM guidelines state that the most consistent risk factors are preexisting dementia; history of hypertension and/or alcoholism; and a high severity of illness at admission (Barr et al. 2013). Other risk factors are sedative and analgesic medications (Bryczkowski et al. 2014; Pandharipande et al. 2008), mechanical ventilation (Pandharipande et al. 2005), restraint use (Bryczkowski et al. 2014; Mehta et al. 2015), age (Pandharipande et al. 2005) and specific medical conditions necessitating ICU care, e.g. sepsis (Agarwal et al. 2013; Lin et al. 2008).
Much work has been done on identifying modifiable risk factors of delirium. One of the most important is the use of analgesic and sedative drugs, drugs that are commonly prescribed to adults in the ICU. For example, patients receiving lorazepam have an increased risk for transitioning to delirium (Pandharipande et al. 2006). Follow-up studies have confirmed that the use of non-benzodiazepine drugs for sedation is associated with improved outcomes including delirium (Pauley et al. 2015; Riker et al. 2009). In the most recent sedation guidelines published by the SCCM there is a recommendation to use non-benzodiazepine sedatives and to consider dexmedetomidine in patients with delirium to potentially reduce the duration of delirium. (Barr et al. 2013). 
Sedation protocols are now commonplace within modern adult ICU practice. Whilst there is conflicting evidence of the overall benefit of protocols (Sevransky et al. 2015), there is evidence that the use of sedation protocols leads to improved patient outcomes by reducing over sedation (Brook et al. 1999; Sessler et al. 2011). Other studies have included spontaneous awakening trials with sedation protocols, and showed decreased overall sedative use and decreased incidence of acute brain dysfunction (Girard et al. 2008; Khan et al. 2014). With the growing use of spontaneous awakening trials, it has also come to light that a small subset of patients will have rapidly reversible sedation-associated delirium. While seen in less than 10% of patients with sedative-associated delirium, these patients tend to portend better outcomes than those with more persistent forms of delirium associated with sedation (Patel et al. 2014). Protocols which optimise sedation and then have physical therapy added to the management practice significantly reduce the duration of delirium in critically ill patients (Schweickert  et al. 2009). 
Risk factors for the development of paediatric delirium have not been thoroughly studied. A recently published small cohort study demonstrated that developmental delay, need for mechanical ventilation and age were associated with delirium (Silver  et al. 2015). The exposure to benzodiazepine administration has been associated with the development of delusional memories and subsequent development of post-traumatic stress disorder in children who survive critical illness (Colville  et al. 2008). Future studies will help describe those risk factors that may be modifiable in the future for children during critical illness.
Outcomes 
It is important to diagnose delirium in the critically ill adult patient, as the presence of delirium is associated with poorer patient outcomes, both short and long term. In the short term there is higher mortality (Ely et al. 2004), especially in patients with >2 days of delirium (Klein Klouwenberg et al. 2014), increased time of mechanical ventilation (Lat et al. 2009), increased ICU and hospital length of stays (Ely et al. 2001b) and increased cost of care. Pandharipande et al. (2013) found that longer durations of ICU delirium were associated with decreased cognitive function after one year and that the level of impairment was similar to that of a moderate traumatic brain injury in almost a third of survivors. 
While the associations between delirium and outcomes have yet to be well defined in children, critical illness has been shown to have long term ramifications. Decreases in spatial and verbal memory, inattention (Fiser 1992), significantly longer school absences (Rees et al. 2004) and development of executive dysfunction months after discharge have been demonstrated among critically ill children who survive to home. Thus there may be elements of critical illness or management factors that exacerbate delirium development and predispose patients to long standing cognitive impairment after discharge.
Prevention and Treatment 
Given the impact of delirium on outcomes, focus on prevention and management has become vital. Unfortunately the pathophysiology of delirium has not been fully elucidated and therefore directed therapies are not currently available. In both adults and children with delirium the prompt identification and treatment of underlying causes such as sepsis, hypoxia, poor oxygen delivery or drug withdrawal should be undertaken, leading to symptom resolution. There are other situations in which the source of delirium cannot be acutely reversed, and rather the focus becomes decreasing factors that may exacerbate or prolong acute brain dysfunction. Non-pharmacological strategies may help maintain orientation and support normal function of brain systems, thus improving outcomes (Inouye et al. 1999). Promotion of the sleepwake cycle is crucial and can usually be achieved by non-pharmacological means. Additionally the ongoing assessment of need for and goal of weaning psychoactive medications should be considered, including the necessary goal for level of consciousness and monitoring and treatment of pain. Non-pharmacological strategies that have been shown to be effective in reducing the incidence and duration of delirium in adults include early mobilisation (Schweickert et al. 2009) and sleep hygiene protocols (Kamdar et al. 2015). One such framework for good sedation and delirium practices is the ABCDE approach, which incorporates Assessment and management of pain; Both spontaneous awakening and breathing trials; Choosing the right sedative; Delirium monitoring and management; and Early exercise has been shown to be effective in reducing delirium (Balas et al. 2013). 
Current pharmacological interventions are focused on treatment of the behavioural expression of delirium, both hyperactive and hypoactive, ranging from excessive agitation or combativeness to withdrawal and apathy (Balas et al. 2013; Smith et al. 2013). There are currently no U.S. Food and Drug Administration-approved medications for treatment of delirium in either adult or paediatric populations. However, both typical and atypical antipsychotics have been used successfully to modify delirium symptoms in both adults and children (Schieveld et al. 2007; Silver et al. 2010). A recent study investigated the use of haloperidol prophylaxis for adult patients with >50% predicated chance of developing delirium. Patients in the treatment group had decreased incidence of delirium and more delirium-coma free days, with the effect most pronounced in those with the highest baseline risk (van den Boogaard et al. 2013). This is consistent with other small studies that have had positive results with the use of antipsychotics for reducing delirium in adults (Skrobik et al. 2004; Devlin et al. 2010; Devlin  et al. 2011). In contrast the HalOPeridol Effectiveness in ICU delirium  (HOPE-ICU) trial, which randomised patients to haloperidol or placebo, showed no benefit in adult ICU patients receiving haloperidol prophylaxis (Page  et al. 2013), nor did the Modifying the INcidence of Delirium (MIND) study comparing typical to atypical antipsychotics to placebo (Girard et al. 2010). The current adult SCCM guidelines thus do not recommend the routine use of any pharmacological prevention strategy for delirium including antipsychotics, but do acknowledge that atypical antipsychotics may reduce the duration of delirium (Devlin et al. 2011).
Conclusion 
Delirium is a major contributor to both in-hospital and outpatient morbidity and mortality. Delirium monitoring and management may help decrease development and duration of delirium in both adults and children. Clearly, institution of a consistent monitoring plan for sedation, pain, and delirium may benefit critically ill patients. Though risk factor and outcome data in adults are better elucidated, further understanding and future studies are required in the paediatric population.

See Also: Sedation in Acute Brain Injury: Less is More?

References:

Adam N, Kandelman S, Mantz J et al. (2013) Sepsis-induced brain dysfunction. Expert Rev Anti Infect Ther, 11(2): 211-21.

 

Agarwal V, O'Neill PJ, Cotton BA et al. (2010) Prevalence and risk factors for development of delirium in burn intensive care unit patients. J Burn Care Res, 31(5): 706-15.

 

American Psychiatric Association, ed. (2013) Diagnostic and Statistical Manual of Mental Disorders. 5th edition. [Accessed: 9 November 2015] Available from dsm.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596

 

Balas MC, Burke WJ, Gannon D et al. (2013) Implementing the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility bundle into everyday care: opportunities, challenges, and lessons learned for implementing the ICU Pain, Agitation, and Delirium Guidelines. Crit Care Med, 41(9 Suppl 1): S116-27.

 

Barr J, Fraser GL, Puntillo K et al. (2013) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the Intensive Care Unit: executive summary. Am J Health Syst Pharm, 70(1): 53-8.

 

Bergeron N, Dubois MJ, Dumont M et al. (2001) Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med, 27(5): 859-64.

 

Brook AD, Ahrens TS, Schaiff R et al.(1999) Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med, 27(12): 2609-15.

 

Bryczkowski SB, Lopreiato MC, Yonclas PP et al.(2014) Risk factors for delirium in older trauma patients admitted to the surgical intensive care unit. J Trauma Acute Care Surg, 77(6): 944-51.

 

Colville G, Kerry S, Pierce C (2008) Children's factual and delusional memories of intensive care.  Am J Respir Crit Care Med, 177(9): 976-82.

 

Devlin JW, Roberts RJ, Fong JJ et al. (2010) Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med, 38(2): 419-27.

 

Devlin JW, Skrobik Y, Riker RR et al. (2011) Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study. Crit Care, 15(5): R215.

 

Ely EW, Inouye SK, Bernard GR et al. (2001) Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA, 286(21): 2703-10.

 

Ely EW, Shintani A, Truman B et al. (2004) Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA, 291(14): 1753-62.

 

Ely EW, Gautam S, Margolin R et al. (2001b) The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med, 27(12): 1892-900.

 

Francis J, Martin D, Kapoor WN (1990) A prospective study of delirium in hospitalized elderly. JAMA, 263(8): 1097-101.

 

Fiser DH (1992) Assessing the outcome of pediatric intensive care. J Pediatr, 121(1): 68-74.

 

Girard TD, Kress JP, Fuchs BD et al. (2008) Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet, 371(9607): 126-34.

 

Girard TD, Pandharipande PP, Carson SS et al. (2010) Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med, 38(2): 428-37.

 

Goben C, Gangopadhyay M, Chestnut MH et al. (2014) Pediatric delirium prevalence and motoric subtypes in critically ill infants and young children.  Crit Care Med, 2(12): A128.

 

Inouye SK, Charpentier PA (1996) Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA, 275(11): 852-7.


Inouye SK, Bogardus ST Jr., Charpentier PA et al. (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med, 340(9): 669-76.


Kamdar BB, Niessen T, Colantuoni E et al. (2015) Delirium transitions in the medical ICU: exploring the role of sleep quality and other factors. Crit Care Med, 43(1):135-41.


Khan BA, Fadel WF, Tricker JL et al. (2014) Effectiveness of implementing a wake up and breathe program on sedation and delirium in the ICU. Crit Care Med, 42(12): e791-5.


Klein Klouwenberg PM, Zaal IJ, Spitoni C et al. (2014) The attributable mortality of delirium in critically ill patients: prospective cohort study. BMJ, 349: g6652.


Lat I, McMillian W, Taylor S et al. (2009) The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients. Crit Care Med, 37(6): 1898-905.


Leentjens AF, Schieveld JN, Leonard M et al. (2008) A comparison of the phenomenology of pediatric, adult, and geriatric delirium. J Psychosom Res, 64(2): 219-23.


Lin SM, Huang CD, Liu CY et al. (2008) Risk factors for the development of early-onset delirium and the subsequent clinical outcome in mechanically ventilated patients. J Crit Care 2008, 23(3): 372-9.


McPherson JA, Wagner CE, Boehm LM et al. (2013) Delirium in the cardiovascular ICU: exploring modifiable risk factors. Crit Care Med, 41(2):405-13.


Meagher DJ, Moran M, Raju B et al. (2007) Phenomenology of delirium. Assessment of 100 adult cases using standardised measures. Br J Psychiatry, 190: 135-41.


Mehta S, Cook D, Devlin JW et al. (2015) Prevalence, risk factors, and outcomes of delirium in mechanically ventilated adults. Crit Care Med, 43(3): 557-66.


Page VJ, Ely EW, Gates S et al.(2013) Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med, 1(7): 515-23.


Pandharipande P, Cotton BA, Shintani A et al. (2008) Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma, 65(1): 34-41.


Pandharipande P, Cotton BA, Shintani A et al. (2007) Motoric subtypes of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med, 33(10): 1726-31.


Pandharipande P, Jackson J, Ely EW (2005) Delirium: acute cognitive dysfunction in the critically ill. Curr Opin Crit Care, 11(4): 360-8.


Pandharipande P, Shintani A, Peterson J et al. (2006) Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology, 104(1): 21-6.


Pandharipande PP, Girard TD, Jackson JC et al. (2013) Long-term cognitive impairment after critical illness. N Engl J Med, 369(14): 1306-16.


Patel SB, Poston JT, Pohlman A et al. (2014) Rapidly reversible, sedation-related delirium versus persistent delirium in the intensive care unit. Am J Respir Crit Care Med, 189(6): 658-65.


Pauley E, Lishmanov A, Schumann S et al. (2015) Delirium is a robust predictor of morbidity and mortality among critically ill patients treated in the cardiac intensive care unit. Am Heart J, 170(1): 79-86.


Pun BT, Devlin JW (2013) Delirium monitoring in the ICU: strategies for initiating and sustaining screening efforts. Semin Respir Crit Care Med, 34(2): 179-88.


Rees G, Gledhill J, Garralda ME et al. (2004) Psychiatric outcome following paediatric intensive care unit (PICU) admission: a cohort study. Intensive Care Med, 30(8): 1607-14.


Riker RR, Shehabi Y, Bokesch PM et al. (2009) Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA, 301(5): 489-99.


Schieveld JN, Leroy PL, Van OsJ et al. (2007) Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit. Intensive Care Med, 33(6): 1033-40. 


Schweickert WD, Pohlman MC, Pohlman AS et al. (2009) Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet, 373(9678): 1874-82.


Sessler CN, Pedram S (2011) Protocolized and target-based sedation and analgesia in the ICU. Anesthesiol Clin, 29(4): 625-50.


Sevransky JE, Checkley W, Herrera P et al. (2015) Protocols and hospital mortality in critically ill patients: the United States critical illness and injury trials group critical illness outcomes study. Crit Care Med, Jun 24 [Epub ahead of print] doi: 10.1097/CCM.0000000000001157


Silver G, Traube C, Gerber L et al. (2015) Pediatric delirium and associated risk factors: a single-center prospective observational study.  Ped Crit Care Med,16(4): 303-9.


Silver GH, Kearney JA, Kutko MC et al. (2010) Infant delirium in pediatric critical care settings. Am J Psychiatry, 167(10): 1172-7.


Skrobik YK, Bergeron N, Dumont M et al. (2004) Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med, 30(3): 444-9.


Smith HA, Boyd J, Fuchs DC et al. (2011) Diagnosing delirium in critically ill children: Validity and reliability of the Pediatric Confusion Assessment Method for the Intensive Care Unit. Crit Care Med, 39(1): 150-7.


Smith HAB, Gangopadhyay M, Goben C et al. (2014) Pediatric delirium in infants and young children: validation of the preschool confusion assessment method for the intensive care unit (psCAM-ICU).  Am J Respir Crit Care Med, 189: A3246.


Smith HA, Brink E, Fuchs DC et al. (2013) Pediatric delirium: monitoring and management in the pediatric intensive care unit. Pediatr Clin North Am, 60(3): 741-60.


Traube C, Silver G, Kearney J et al. (2014) Cornell Assessment of Pediatric Delirium: a valid, rapid, observational tool for screening delirium in the PICU*. Crit Care Med, 42(3): 656-63.


Turkel SB, Trzepacz PT, Tavaré CJ (2006) Comparing symptoms of delirium in adults and children. Psychosomatics, 47(4): 320-4.


van den Boogaard M, Schoonhoven L, van AT et al. (2013) Haloperidol prophylaxis in critically ill patients with a high risk for delirium. Crit Care, 17(1): R9.


Zhang WY, Wu WL, Gu JJ et al. (2015) Risk factors for postoperative delirium in patients after coronary artery bypass grafting: A prospective cohort study. J Crit Care, 30(3): 606-12.




Print as PDF

Delirium, ICU, Acute Brain Dysfunction Delirium is a major contributor to both in-hospital and outpatient morbidity and mortality. Delirium monitoring and management may help decrease development and duration of delirium in both adults and children. A consistent monitoring plan for sedation, p

No comment


Please login to leave a comment...

Highlighted Products